Clinical relevance of IL-6 and lactate levels within 24 hours of ICU admission of COVID-19 patients in predicting mortality rate

被引:1
|
作者
Nugroho, Andy [1 ]
Santoso, Sugeng Budi [1 ]
Permana, Septian Adi [1 ]
Hapsari, Paramita Putri [1 ]
Sitompul, Harles [1 ]
机构
[1] Sebelas Maret Univ, Dr Moewardi Gen Hosp, Dept Anesthesiol & Intens Therapy, Fac Med, Surakarta, Cent Java, Indonesia
关键词
IL-6; Lactate; ICU; COVID-19; SARS-CoV-2; CORONAVIRUS DISEASE 2019;
D O I
10.35975/apic.v26i5.2032
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background & objective: Patients with COVID-19 have Acute Respiratory Distress Syndrome (ARDS) which progresses to lung edema and disorders of the liver, kidneys and heart associated with cytokine storms, which are the body's immune response to SARS-CoV-2. SARS-CoV-2 patients showed clinical neutrophilia, increased D-Dimer and increased IL-6. In addition, increased lactate dehydrogenase and increased aminotransferase are often found. This study aimed to analyze the clinical relevance of increased IL-6 and lactate in the first 24 hours of ICU-admission of COVID-19 patients in predicting mortality rate. Methodology: This study was a retrospective cohort design. The study was conducted in the Intensive Care Unit (ICU) of Dr. Moewardi Surakarta Hospital. The study was conducted by tracing the medical records of COVID-19 patients treated in the ICU of Dr. Moewardi Surakarta Hospital during the period of March 1, 2020 to March 31, 2021 that met the admission criteria. The patient's mortality assessment is seen as the patient's condition for a maximum of 30 days after discharge from the hospital. Results: Variables that meet the regression model are the lactate levels (OR = 3,143; P = 0.064) as well as the IL-6 levels (OR = 25.41; p<0.001). AUC score of 86.9% with significance of < 0.001. IL-6 levels and lactate levels in the study can be used as predictors of mortality rates with 95.7% sensitivity and 60% specificity. Lactate levels in COVID-19 cases in severe cases can be related to lung damage and tissue damage. Lactate levels have also been recognized as a marker of poor prognosis in patients with COVID- 19. IL-6 as a predictor of mortality risk has been recognized and the administration of IL-6 inhibitors in COVID-19 patients may lower the risk of mortality. Conclusion: Raised IL-6 and lactate levels in this study can be a predictor of the mortality rate of COVID-19 patients within 24 hours of ICU-admission.
引用
收藏
页码:689 / 694
页数:6
相关论文
共 50 条
  • [31] Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes
    Lei, Ming
    Lin, Kashuai
    Pi, Yaoqiu
    Huang, Xiaomei
    Fan, Lixin
    Huang, Jun
    Liu, Riguang
    Liu, Lin
    Shao, Xinning
    Hu, Kaiyuan
    Yang, Liuping
    Qin, Shuguang
    He, Feng
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [32] Unstructured clinical notes within the 24 hours since admission predict short, mid & long-term mortality in adult ICU patients
    Mahbub, Maria
    Srinivasan, Sudarshan
    Danciu, Ioana
    Peluso, Alina
    Begoli, Edmon
    Tamang, Suzanne
    Peterson, Gregory D.
    PLOS ONE, 2022, 17 (01):
  • [33] Interpretable deep learning for the prediction of ICU admission likelihood and mortality of COVID-19 patients
    Nazir, Amril
    Ampadu, Hyacinth Kwadwo
    PEERJ COMPUTER SCIENCE, 2022, 8
  • [34] Can we predict which COVID-19 patients will need transfer to intensive care within 24 hours of floor admission?
    Wang, Alfred Z.
    Ehrman, Robert
    Bucca, Antonino
    Croft, Alexander
    Glober, Nancy
    Holt, Daniel
    Lardaro, Thomas
    Musey, Paul
    Peterson, Kelli
    Schaffer, Jason
    Trigonis, Russell
    Hunter, Benton R.
    ACADEMIC EMERGENCY MEDICINE, 2021, 28 (05) : 511 - 518
  • [35] Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
    Samuel J. Minkove
    Grant Geiger
    Josep M. Llibre
    Mary W. Montgomery
    Natalie E. West
    Natasha M. Chida
    Annukka A. R. Antar
    Dima Dandachi
    Ethel D. Weld
    AIDS Research and Therapy, 19
  • [36] Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
    Minkove, Samuel J.
    Geiger, Grant
    Llibre, Josep M.
    Montgomery, Mary W.
    West, Natalie E.
    Chida, Natasha M.
    Antar, Annukka A. R.
    Dandachi, Dima
    Weld, Ethel D.
    AIDS RESEARCH AND THERAPY, 2022, 19 (01)
  • [37] Admission Levels of Serum P-Selectin and IL-6 Can Predict Development of Deep Venous Thrombosis in Hospitalized Covid-19 Patients
    Farouk, Nehal
    Ashry, Walaa Mohamed Omar
    El-Hagrasy, Hanan A.
    Mohamed, Eman F.
    Eltrawy, Heba H.
    El-Nasser, Asmaa M.
    Shipl, Walaa
    El Attar, Shahinaz
    Sakr, Lobna Kh
    Wahab, Maisa A. Abdel
    Abdelsalam, Eman M.
    Sharaf, Fawzia A.
    Ahmad, Inass Hassan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 5599 - 5607
  • [38] Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
    Flisiak, Robert
    Jaroszewicz, Jerzy
    Rogalska, Magdalena
    Lapinski, Tadeusz
    Berkan-Kawinska, Aleksandra
    Bolewska, Beata
    Tudrujek-Zdunek, Magdalena
    Kozielewicz, Dorota
    Rorat, Marta
    Leszczynski, Piotr
    Klos, Krzysztof
    Kowalska, Justyna
    Pabjan, Pawel
    Piekarska, Anna
    Mozer-Lisewska, Iwona
    Tomasiewicz, Krzysztof
    Pawlowska, Malgorzata
    Simon, Krzysztof
    Polanska, Joanna
    Zarebska-Michaluk, Dorota
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [39] IL-6 modulation for COVID-19: the right patients at the right time?
    Ascierto, Paolo Antonio
    Fu, Binqing
    Wei, Haiming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
  • [40] Usefulness of day-one chest X-ray score for predicting mortality and ICU admission in COVID-19 patients
    Hoang, T.
    Tran, H. D.
    Tran, D. T.
    Dang, M. C.
    Ton-Nu, T.
    Trinh, L. H. M.
    Le, H. H. N.
    Le Thi, N. M.
    Cong, T. Tran
    Dong, D. N. N.
    Dinh-Xuan, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60